The Korean Journal of Urological Oncology10.22465/kjuo.2022.20.2.82202220282-91The Present and Future of Intravesical Therapy in Bladder CancerSin-Woo Seong, Youngjae Shin, In Ho Chang, Jung Hoon Kim,,
Molecular Therapy10.1016/s1525-0016(16)44608-3200715S155402. Comparison of Intravesical lnterleukin-12 Gene Therapy and Intravesical BCG Therapy in an Orthotopic Bladder Cancer Model,
Bladder Cancer10.1016/b978-0-12-809939-1.00021-72018327-334Treatment of Failure of Intravesical TherapySunghyun Paick,
Bladder Cancer10.3233/blc-19901120206197-98Intravesical Coxsackievirus A21 Therapy for Non-Muscle Invasive Bladder CancerEdward Messing
Bladder Cancer10.3233/blc-160056201623285-292The Future of Intravesical Drug Delivery for Non-Muscle Invasive Bladder CancerLaura Douglass, Mark Schoenberg
Bladder Cancer10.3233/blc-179023201734313-314Bladder Sparing Therapy for BCG Failures – I – Intravesical ImmunotherapyEdward M. Messing
Molecular Therapy10.1016/s1525-0016(16)40749-5200375S122307. Intravesical Gene Therapy for Superficial Bladder Cancer with Syn3/Ad-α IFN,
BJU International10.1111/j.1464-410x.2011.10880.x20121094496-505Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic reviewMike D. Shelley, Gabriel Jones, Anne Cleves, Timothy J. Wilt, Malcolm D. Mason, Howard G. Kynaston,
Bladder Cancer10.1007/978-3-030-70646-3_9202175-89Adjuvant Intravesical Therapy: Bacillus Calmette-GuerinGautier Marcq, Wassim Kassouf
Urology10.1016/s0090-4295(99)00463-x2000552161-168Intravesical therapy for bladder cancerAshish M Kamat, Donald L Lamm,